Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

North America Antiplatelet Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, and Injectable), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

Published Date : 30-Sep-2023

Pages: 128

Formats: PDF

The North America Antiplatelet Market would witness market growth of 4.0% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 152.5 million Units, showcasing a growth of 2.8% (2019-2022).

A drug that inhibits thrombus formation and decreases platelet aggregation is considered an antiplatelet drug. They have a positive effect on the arterial circulation. They are frequently employed to prevent primary and secondary thrombotic cerebrovascular or cardiovascular disease. The prevention and treatment of antithrombotic drugs, which include anticoagulants, ischemic events, antiplatelet drugs, and thrombolytic drugs, are used for a wide range of indications. These include peripheral occlusion (PAO), venous thromboembolism (VTE), acute coronary syndrome (ACS), myocardial infarction (MI), and stroke.

Antiplatelet drugs lower the incidence of cardiovascular events like heart attacks and strokes. In clinical trials and research investigations, they help inhibit platelet aggregation and lower the formation of blood clots. These drugs' sustained use and market expansion are propelled by the positive outcomes associated with them. Enhanced awareness of cardiovascular disease risk factors and symptoms has enhanced diagnosis rates. The increased prevalence of routine screenings and early detection of these conditions are raising the demand for antiplatelet medications as preventative and therapeutic measures.

According to Centers for Disease Control and Prevention (CDC), in the United States, heart disease is the primary cause of death for men and women. In the United States, cardiovascular disease kills one person every 33 seconds. Approximately 695,000 individuals perished from heart disease in 2021, or one out of every five deaths. From 2018 to 2019, heart disease cost the United States roughly $239.9 billion annually. This includes the cost of health care services, medications, and productivity lost due to mortality. Consequently, the increase in cardiovascular disease prevalence drives the demand for antiplatelet medications to treat these conditions. Thus, owing to the aforementioned elements, the market will grow rapidly in the coming years.

The US market dominated the North America Antiplatelet Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,473.5 Million by 2030. The Canada market is experiencing a CAGR of 6.4% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 5.5% during (2023 - 2030).

Based on Route of Administration, the market is segmented into Oral, and Injectable. Based on Drug Class, the market is segmented into Adenosine diphosphate (ADP) Receptor Inhibitors, Irreversible Inhibitors Cyclooxygenase, and Others. Based on Distribution Channel, the market is segmented into Drug store & Retail Pharmacies, Hospital Pharmacies, and Online Providers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

Free Valuable Insights: The Antiplatelet Market is Predict to reach $5.1 Billion by 2030, at a CAGR of 4.7%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cipla Limited, Glenmark Pharmaceuticals Limited, Bayer AG, AstraZeneca PLC, Daiichi Sankyo Company, Limited, Eli Lilly And Company, Otsuka Pharmaceutical Co., Ltd., Sanofi S.A. , Lupin Limited and Chiesi Farmaceutici S.p.A.

Scope of the Study

Market Segments Covered in the Report:

By Route of Administration (Volume, Million Units, USD Million, 2019-2030)

  • Oral
  • Injectable

By Drug Class (Volume, Million Units, USD Million, 2019-2030)

  • Adenosine diphosphate (ADP) Receptor Inhibitors
  • Irreversible Inhibitors Cyclooxygenase
  • Others

By Distribution Channel (Volume, Million Units, USD Million, 2019-2030)

  • Drug store & Retail Pharmacies
  • Hospital Pharmacies
  • Online Providers

By Country (Volume, Million Units, USD Million, 2019-2030)

  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players

List of Companies Profiled in the Report:

  • Cipla Limited
  • Glenmark Pharmaceuticals Limited
  • Bayer AG
  • AstraZeneca PLC
  • Daiichi Sankyo Company, Limited
  • Eli Lilly And Company
  • Otsuka Pharmaceutical Co., Ltd.
  • Sanofi S.A.
  • Lupin Limited
  • Chiesi Farmaceutici S.p.A
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Antiplatelet Market, by Route of Administration
1.4.2 North America Antiplatelet Market, by Drug Class
1.4.3 North America Antiplatelet Market, by Distribution Channel
1.4.4 North America Antiplatelet Market, by Country
1.5 Methodology for the research

Chapter 2. Market At a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis

Chapter 4. North America Antiplatelet Market by Route of Administration
4.1 North America Oral Market by Country
4.2 North America Injectable Market by Country

Chapter 5. North America Antiplatelet Market by Drug Class
5.1 North America Adenosine diphosphate (ADP) Receptor Inhibitors Market by Country
5.2 North America Irreversible Inhibitors Cyclooxygenase Market by Country
5.3 North America Others Market by Country

Chapter 6. North America Antiplatelet Market by Distribution Channel
6.1 North America Drug store & Retail Pharmacies Market by Country
6.2 North America Hospital Pharmacies Market by Country
6.3 North America Online Providers Market by Country

Chapter 7. North America Antiplatelet Market by Country
7.1 US Antiplatelet Market
7.1.1 US Antiplatelet Market by Route of Administration
7.1.2 US Antiplatelet Market by Drug Class
7.1.3 US Antiplatelet Market by Distribution Channel
7.2 Canada Antiplatelet Market
7.2.1 Canada Antiplatelet Market by Route of Administration
7.2.2 Canada Antiplatelet Market by Drug Class
7.2.3 Canada Antiplatelet Market by Distribution Channel
7.3 Mexico Antiplatelet Market
7.3.1 Mexico Antiplatelet Market by Route of Administration
7.3.2 Mexico Antiplatelet Market by Drug Class
7.3.3 Mexico Antiplatelet Market by Distribution Channel
7.4 Rest of North America Antiplatelet Market
7.4.1 Rest of North America Antiplatelet Market by Route of Administration
7.4.2 Rest of North America Antiplatelet Market by Drug Class
7.4.3 Rest of North America Antiplatelet Market by Distribution Channel

Chapter 8. Company Profiles
8.1 Cipla Limited
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Glenmark Pharmaceuticals Limited
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Approvals:
8.2.6 SWOT Analysis
8.3 Bayer AG
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 AstraZeneca PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 Daiichi Sankyo Company, Limited
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Product and Services and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Eli Lilly And Company
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Otsuka Pharmaceutical Co., Ltd.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Sanofi S.A.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Lupin Limited
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Chiesi Farmaceutici S.p.A
8.10.1 Company Overview
8.10.2 SWOT Analysis
TABLE 1 North America Antiplatelet Market, 2019 - 2022, USD Million
TABLE 2 North America Antiplatelet Market, 2023 - 2030, USD Million
TABLE 3 North America Antiplatelet Market, 2019 - 2022, Million Units
TABLE 4 North America Antiplatelet Market, 2023 - 2030, Million Units
TABLE 5 North America Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 6 North America Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 7 North America Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 8 North America Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 9 North America Oral Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Oral Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Oral (strip of 10) Market by Country, 2019 - 2022, Million Units
TABLE 12 North America Oral (strip of 10) Market by Country, 2023 - 2030, Million Units
TABLE 13 North America Injectable Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Injectable Market by Country, 2023 - 2030, USD Million
TABLE 15 North America Injectable Market by Country, 2019 - 2022, Million Units
TABLE 16 North America Injectable Market by Country, 2023 - 2030, Million Units
TABLE 17 North America Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 18 North America Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 19 North America Adenosine diphosphate (ADP) Receptor Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Adenosine diphosphate (ADP) Receptor Inhibitors Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Irreversible Inhibitors Cyclooxygenase Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Irreversible Inhibitors Cyclooxygenase Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 25 North America Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 26 North America Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 27 North America Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 28 North America Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 29 North America Drug store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 30 North America Drug store & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 31 North America Drug store & Retail Pharmacies Market by Country, 2019 - 2022, Million Units
TABLE 32 North America Drug store & Retail Pharmacies Market by Country, 2023 - 2030, Million Units
TABLE 33 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 34 North America Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 35 North America Hospital Pharmacies Market by Country, 2019 - 2022, Million Units
TABLE 36 North America Hospital Pharmacies Market by Country, 2023 - 2030, Million Units
TABLE 37 North America Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 38 North America Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 39 North America Online Providers Market by Country, 2019 - 2022, Million Units
TABLE 40 North America Online Providers Market by Country, 2023 - 2030, Million Units
TABLE 41 North America Antiplatelet Market by Country, 2019 - 2022, USD Million
TABLE 42 North America Antiplatelet Market by Country, 2023 - 2030, USD Million
TABLE 43 North America Antiplatelet Market by Country, 2019 - 2022, Million Units
TABLE 44 North America Antiplatelet Market by Country, 2023 - 2030, Million Units
TABLE 45 US Antiplatelet Market, 2019 - 2022, USD Million
TABLE 46 US Antiplatelet Market, 2023 - 2030, USD Million
TABLE 47 US Antiplatelet Market, 2019 - 2022, Million Units
TABLE 48 US Antiplatelet Market, 2023 - 2030, Million Units
TABLE 49 US Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 50 US Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 51 US Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 52 US Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 53 US Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 54 US Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 55 US Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 56 US Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 57 US Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 58 US Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 59 Canada Antiplatelet Market, 2019 - 2022, USD Million
TABLE 60 Canada Antiplatelet Market, 2023 - 2030, USD Million
TABLE 61 Canada Antiplatelet Market, 2019 - 2022, Million Units
TABLE 62 Canada Antiplatelet Market, 2023 - 2030, Million Units
TABLE 63 Canada Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 64 Canada Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 65 Canada Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 66 Canada Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 67 Canada Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 68 Canada Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 69 Canada Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 70 Canada Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 71 Canada Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 72 Canada Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 73 Mexico Antiplatelet Market, 2019 - 2022, USD Million
TABLE 74 Mexico Antiplatelet Market, 2023 - 2030, USD Million
TABLE 75 Mexico Antiplatelet Market, 2019 - 2022, Million Units
TABLE 76 Mexico Antiplatelet Market, 2023 - 2030, Million Units
TABLE 77 Mexico Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 78 Mexico Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 79 Mexico Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 80 Mexico Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 81 Mexico Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 82 Mexico Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 83 Mexico Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 84 Mexico Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 85 Mexico Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 86 Mexico Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 87 Rest of North America Antiplatelet Market, 2019 - 2022, USD Million
TABLE 88 Rest of North America Antiplatelet Market, 2023 - 2030, USD Million
TABLE 89 Rest of North America Antiplatelet Market, 2019 - 2022, Million Units
TABLE 90 Rest of North America Antiplatelet Market, 2023 - 2030, Million Units
TABLE 91 Rest of North America Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 92 Rest of North America Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 93 Rest of North America Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 94 Rest of North America Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 95 Rest of North America Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 96 Rest of North America Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 97 Rest of North America Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 98 Rest of North America Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 99 Rest of North America Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 100 Rest of North America Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 101 Key Information – Cipla Limited
TABLE 102 Key Information – Glenmark Pharmaceuticals Limited
TABLE 103 Key Information – Bayer AG
TABLE 104 KEY INFORMATION – AstraZeneca PLC
TABLE 105 Key Information – Daiichi Sankyo Company, Limited
TABLE 106 Key Information – Eli Lilly And Company
TABLE 107 key information – Otsuka Pharmaceutical Co., Ltd.
TABLE 108 Key Information – Sanofi S.A.
TABLE 109 Key Information – Lupin Limited
TABLE 110 Key Information – Chiesi Farmaceutici S.p.A

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Antiplatelet Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting the Antiplatelet Market
FIG 4 Porter’s Five Force Analysis: Antiplatelet Market
FIG 5 North America Antiplatelet Market share by Route of Administration, 2022
FIG 6 North America Antiplatelet Market share by Route of Administration, 2030
FIG 7 North America Antiplatelet Market by Route of Administration, 2019 - 2030, USD Million
FIG 8 North America Antiplatelet Market share by Drug Class, 2022
FIG 9 North America Antiplatelet Market share by Drug Class, 2030
FIG 10 North America Antiplatelet Market by Drug Class, 2019 - 2030, USD Million
FIG 11 North America Antiplatelet Market share by Distribution Channel, 2022
FIG 12 North America Antiplatelet Market share by Distribution Channel, 2030
FIG 13 North America Antiplatelet Market by Distribution Channel, 2019 - 2030, USD Million
FIG 14 North America Antiplatelet Market share by Country, 2022
FIG 15 North America Antiplatelet Market share by Country, 2030
FIG 16 North America Antiplatelet Market by Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Cipla Limited
FIG 18 SWOT Analysis: Glenmark Pharmaceuticals Limited
FIG 19 Swot Analysis: Bayer AG
FIG 20 SWOT Analysis: AstraZeneca PLC
FIG 21 SWOT Analysis: Daiichi Sankyo Company, Limited
FIG 22 Swot Analysis: Eli Lilly And Company
FIG 23 Swot Analysis: Otsuka Pharmaceutical Co., Ltd.
FIG 24 Swot Analysis: Sanofi S.A.
FIG 25 SWOT Analysis: Lupin Limited
FIG 26 SWOT Analysis: Chiesi Farmaceutici S.p.A

Purchase Full Report of
North America Antiplatelet Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL